Amphipathic carboxylates, of varying hydrophobic backbones, which act as peroxisomal proliferators (aryloxyalkanoic acids, methyl-substituted dicarboxylic acid) induce in euthyroid or thyroidectomized rats, as well as in rat hepatocytes cultured in 3,5,3'-tri-iodo-L-thyronine (Tq)-free media, liver enzyme activities that are classically considered to be thyroidhormone-dependent (malic enzyme, mitochondrial a-glycerophosphate dehydrogenase, glucose-6-phosphate dehydrogenase and S14). The dose required in vivo for the thyromimetic effect of peroxisomal proliferators was 103-fold higher than the dose of T3 required. Similarly, peroxisomal proliferators were active in culture in the range 1-100 ,UM compared with 1 nm for T3. Their maximal inductive capacities were, however, similar to or greater than that of T3. The thyromimetic effect of peroxisomal proliferators was only partially correlated with their capacities as inducers of liver peroxisomal enzymes. The thyromimetic effect with respect to liver malate dehydrogenase and S14 resulted from an increase in their mRNA contents. The increase in liver S14 mRNA was accounted for by transcriptional activation of the S14 gene. T3 binding to isolated liver nuclei or nuclear extract was competitively displaced by some but not all of the nonthyroidal inducers of the above liver activities. In contrast with the thyromimetic effect induced in liver cells, no increase in growth hormone mRNA was observed in cultured GH1 pituitary cells incubated in the presence of non-thyroidal amphipathic carboxylates. The characteristics of the thyromimetic effect of amphipathic carboxylic peroxisomal proliferators indicate that these agents may act as transcriptional activators of thyroid-hormone-dependent genes in the rat liver.
INTRODUCTION
Amphipathic carboxylates ofvarying structural characteristics, e.g. aryloxyalkanoic acids or esters (clofibrate [1] , bezafibrate [2] , nafenopin [3] ), phthalate plasticizers (di-2-ethylhexylphthalate [4] ), native long-chain fatty acids [5] or substituted long-chain dicarboxylic acids [6, 7] have been repeatedly reported to induce liver peroxisomal proliferation and specific peroxisomal enzyme activities in rodents and other species (reviewed in [8, 9] ). The peroxisomal activities induced by peroxisomal proliferators were reported to result from a selective increase in the transcription rate of peroxisomal fl-oxidative genes, with concomitant increases in their respective mRNAs [10, 11] . Thyroid hormones (reviewed in [12, 13] ) appear to share some of the basic characteristics of peroxisomal proliferators. Indeed, thyroid hormones may be generally classified as amphipathic carboxylates, having a carboxyl function carried on a hydrophobic iodinated diphenoxy backbone. Also, similarly to peroxisomal proliferators [14, 15] , thyroid hormones may induce conversion of preadipocytes into matured fat cells [16] , as well as serving as effective hypolipidaemic agents (reviewed in [17] ). Moreover, thyroxine was recently reported to induce peroxisomal proliferation in the rat liver [18] , even though this was significantly less extensive than that induced by typical peroxisomal proliferators. These characteristics that are shared by thyroid hormones and peroxisomal proliferators have tempted us to question whether typical members of the group of peroxisomal proliferators might act as thyromimetic agents, capable of directly inducing liver activities classically considered to be thyroid-hormone-dependent. An increase in liver malic enzyme (EC 1.1. 1.40) activity in clofibrate-treated rats has been previously reported [19, 20] but proposed to be secondarily mediated by competitive displacement of thyroid hormones from their plasma binding sites or by modulation of the insulin/glucagon hormonal balance. The present report indeed shows that various peroxisomal proliferators, which are structurally not related to thyroid hormones, directly induce thyroid-hormone-dependent liver functions.
MATERIALS AND METHODS Animals
Euthyroid male albino rats weighing 150-200 g were fed for 6 consecutive days with laboratory chow diet containing nafenopin, bezafibrate, dehydroepiandrosterone (DHEA) or 3,3,14,14- tetramethylhexadecanedioic acid (MEDICA 16) as stated [% (w/w) of the administered diet]. For hormonal induction, the animals were injected intraperitoneally for 6 consecutive days with 15 ,ug of tri-iodothyronine (T3) or tri-iodothyroacetic acid (Triac)/100 g body per day. Hypothyroid rats were obtained either by surgical parathyrothyroidectomy or by methimazole treatment (0.025 % methimazole added to the drinking water) of male rats weighing 120 g. A hypothyroid state was reflected by the cessation of weight gain and confirmed by measurement of serum T3 levels, which were 38 + 12 1tg/dl on the day of death. At 5 weeks after thyroidectomy or methimazole treatment the animals were treated either with the above drugs administered by stomach tube for 14 days as stated or with T3 or Triac as described above for euthyroid animals.
Cultured cells
Cultured rat hepatocytes were prepared as previously described [5] . Cells were plated on rat-tail-collagen gel prepared according to [21] and grown in RPMI 1640 medium containing 10 % (v/v) fetal calf serum (rendered T3-free by charcoal treatment), 100 munits of insulin/ml, 10 ,ug of cortisol/ml, 50 [22] and [23] respectively, using the cytosolic fraction from either whole liver or cultured hepatocytes. Mitochondrial a-glycerophosphate dehydrogenase (EC 1.1.99.5) activity was measured according to [24] using either the mitochondriaenriched fraction of rat liver or the 100000 g pellet of cultured hepatocytes. Peroxisomal enoyl-CoA hydratase (EC 4.2.1.17) in liver or cultured cell homogenates was determined as previously described [6] . Protein was determined according to [25, 26] .
RNA preparation and analysis Liver or GH1 cell total RNA was prepared using guanidium thiocyanate and was centrifuged through a CsCl cushion according to [27] . The RNA was analysed by Northern blot analysis [28] and quantified by dot-blot hybridization [29] . For Northern blot hybridization [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ,ug of total RNA was loaded on the agarose gel. For dot-blot analysis 1-16 jug of total RNA was denatured with formaldehyde and blotted on Nytran. Hybridization values were linearly related to the blotted RNA content. After hybridization with the respective molecular probes the blots were exposed to X-ray film and the autoradiograms were evaluated densitometrically.
Run-on transcription assay
Rat liver nuclei were isolated as described in [30] . Nuclei were stored at -70°C in storage buffer containing 50 % (w/v) glycerol, 50 mM-Hepes (pH 7.8), 1 mM-MgCl2, 4 mM-MnCl2 and 0.1 mM-EDTA. Transcription assays were carried out as described in [10] , using nuclei samples amounting to 15 [31] and hybridized for 48 h at 65°C in 1 ml of 50 mM-Hepes (pH 7.5)/0.5 M-NaCl/10 mM-EDTA/0.2 % SDS/0.5 mM-UTP/ 0.2 0/0 Ficoll/0.02 00 polyvinylpyrrolidone/0.2 0/0 BSA/300 jug of salmon-sperm DNA/ml to 2 ,ug of the respective plasmid DNAs (pAlbl, pS14-C2, pMJ26, pMJ125, pBR322) affixed to Nytran.
The washed blots were exposed to X-ray film and the radioactivity was then quantified by liquid scintillation counting. Radioactivity hybridized to pBR322 served as background and was subtracted from each experimental value. Transcriptional activity was expressed relative to that of albumin.
Molecular probes S14 mRNA levels were determined using the 610 bp PstI restriction fragment excised from the recombinant DNA pS14-C2 [32] obtained from H. Towle (University of Minnesota, Minneapolis, MN, U.S.A.). Malic enzyme mRNA levels were determined using the 1000 bp pair EcoRI restriction fragment excised from the recombinant DNA pME6 [33] obtained from V. Nikodem (NIH, Bethesda, MD, U.S.A.). Albumin mRNA levels were determined using the 1000 bp HindlIl restriction fragment excised from the recombinant DNA pAlbl [34] obtained from S. M. Tilghman (Princeton University, Princeton, NJ, U.S.A.). Peroxisomal enoyl-CoA hydratase mRNA levels were determined using the 2324 bp EcoRI restriction fragment excised from the recombinant DNA pMJ26 [35] . Peroxisomal palmitoyl-CoA oxidase mRNA was probed by using the pMJ125 plasmid [36] . Growth hormone mRNA was determined using the 800 bp PstI restriction fragment excised from the recombinant DNA pGH 1 [37] . cDNA probes were 32P-labelled by nick-translation [38] .
Nuclear binding of L-13'-1251JT3
Receptor binding in vitro was determined using either isolated liver nuclei or a nuclear extract. Nuclei prepared by sedimentation of rat liver homogenate through high-density sucrose solution [30] were further washed twice with 0.25 M-sucrose containing 2 mM-MgCl2, 20 mM-Tris/HCl, pH 7.5, and 0.5 % Triton X-100. For binding studies with isolated nuclei the pellet was suspended in 0.25 M-sucrose containing 50 mM-NaCl, 20 mM-Tris/HCI, pH 7.5, 1 mM-EDTA and 5 
in the presence of increasing concentrations of either nonradioactive T3 or peroxisomal proliferators was determined according to [39] . DHEA was either suspended in the reaction mixture by sonication or dissolved first in ethanol and then added to the reaction mixture. For binding studies with solubilized receptors the nuclei pellet was solubilized and the binding of L-[3'-125I]T3 to the nuclear extract was determined according to [40] .
Materials
MEDICA 16 was synthesized according to [7] . Nafenopin was from Ciba-Geigy. Bezafibrate was from Boehringer Mannheim. 
RESULTS
The thyromimetic effects of peroxisomal proliferators were studied in the rat in vivo by measuring the increase in the hepatic specific activities of several thyroid-hormone-dependent enzymes, e.g. malic enzyme, mitochondrial c-glycerophosphate dehydrogenase, glucose-6-phosphate dehydrogenase and S14, induced by peroxisomal proliferators of varying structural characteristics. These included bezafibrate and nafenopin, which present two fibrate carboxylates of variable hydrophobic backbones, MEDICA 16, consisting of a substituted long-chain CoA hydratase under conditions where its effects with respect to malic enzyme, mitochondrial a-glycerophosphate dehydrogenase and S14 were clearly observed ( Table 1 ).
The thyromimetic effect of peroxisomal proliferators as reported here was not mediated by an increase in the overall production of thyroid hormones nor in the availability of the free hormone due to competition between peroxisomal proliferators and thyroid hormone binding proteins. Thus the thyromimetic effects of nafenopin and MEDICA 16 were evident in thyroidectomized ( (Fig. 1) .
The thyromimetic effects induced in cultured rat hepatocytes by nafenopin and MEDICA 16 were time-dependent and were accounted for by increases in the mRNAs of malic enzyme and S14 (Fig. 2) . The time course of the thyromimetic effect in culture lagged behind that observed for the induction of enoylCoA hydratase mRNA (Fig. 2) 16 29. stabilization of the S14 transcript by peroxisomal proliferators was evaluated by studying the rate of transcription of the S14
gene as compared with the S14 mRNA content in animals treated with either nafenopin or MEDICA 16. The run-on transcription rate was normalized in each case to that of the albumin gene, since the rate of transcription of the latter was reported to remain unaffected by T3 [44] , and its mRNA content remained unaffected by nafenopin or MEDICA 16 treatment (results not shown). As shown in Table 3 (expt. A), the rate of transcription of S14 in nafenopin-or MEDICA 16-treated thyroidectomized rats was increased 3-4-fold compared with non-treated animals. This increase in the S14 transcription rate was similar in magnitude to the increases in S14 mRNA content induced by nafenopin or MEDICA 16 in thyroidectomized rats (Table 2 ). In contrast with thyroidectomized rats, the rate of transcription of S14 remained unaffected in euthryroid rats treated with nafenopin or MEDICA 16 (Table 3 , expt. B), in line with their ineffectiveness in increasing the S14 mRNA content in these animals (Table 1) . Hence the thyromimetic effects of nafenopin and MEDICA 16 with respect to S14 may essentially be accounted for by increased transcriptional activation of the S14 gene.
The possible binding of peroxisomal proliferators to the thyroid hormone nuclear receptor was evaluated by measuring the displacement of L-[3'-125I]T3 tracer using either rat liver nuclei or a nuclear extract. As shown in Fig. 3, L-[3'-125I [45] , perfluorodecanoic acid [46] or halothane metabolites [47] may be explained within the framework of the thyromimetic effect of peroxisomal proliferators reported here. The variety of the functions induced by the variety of the compounds employed points to the general principle involved and may indicate that peroxisomal proliferators should be grossly considered as proper thyromimetic agents in the rat liver. However, in contrast with T3, which is active in vivo and in culture in the range of micrograms/100 g body wt. and at 1 nm, respectively, the thyromimetic effects of peroxisomal proliferators were evident in the range of milligrams/100 g body wt. and at 1-100 fLM, respectively. The maximal thyromimetic effect of peroxisomal proliferators, however, was similar to or exceeded that of T3. The thyromimetic effects of peroxisomal proliferators were only partially correlated with their capacities as inducers of peroxisomal enzymes or liver growth, and in contrast with thyroxine [18] , T3 and Triac were completely ineffective as inducers of peroxisomal functions.
In contrast with the dual effect of T3 on S14 expression, where transcriptional activation is accompanied by stabilization of the S14 nuclear transcript ( [48, 49] ; note however the alternative view presented in [50] ), the thyromimetic effect of peroxisomal proliferators with respect to S14 appears to be exclusively due to Vol. 274 transcriptional activation (Tables 2 and 3 ). In the absence of S14 transcript stabilization by peroxisomal proliferators, and since transcriptional activation of the S14 gene by T3 approaches saturation at T3 concentrations within the range prevailing in the euthyroid rat [48, 49] , transcriptional activation of the S14 gene by peroxisomal proliferators may be verified in hypothyroid rats only (Table 1 versus Table 2 [52] but not in the hypothyroid rat [52] or in culture (Fig. 1) [52] . These dissimilarities between the characteristics of T3 and peroxisomal proliferators may thus indicate that liver transcriptional activation induced by non-thyroidal amphipathic carboxylates does not directly involve the thyroid hormone nuclear receptor and is presumably mediated by a mechanism of action which differs from that initiated by thyroid hormones proper.
The thyromimetic effects of peroxisomal proliferators may indicate that, in spite of the structural diversity involved, thyroid hormones and xenobiotic amphipathic carboxylates may be grouped into a unified class of compounds structurally defined as having a carboxylic function carried on a hydrophobic backbone and functionally defined by the spectrum of liver activities induced by members of the series. The broad spectrum of compounds that may be considered to be members of the above class could serve as a basis for promoting and extending the synthesis of thyroid hormone functional analogues having a structure totally different from that of the iodinated diphenoxy backbone but that are still active as liver thyromimetic agents. The lower efficacy of these analogues as compared with thyroid hormones could be offset by the advantageous selectivity of such agents with respect to tissue specificity and differential action.
Note added in proof (received 29 January 1991) A member of the steroid hormone receptor superfamily activated by a diverse class of peroximal proliferators has been recently cloned [53] . Being a member of the steroid hormone receptor superfamily makes this receptor a candidate of choice for transducing the thyromimetic effect of peroxisomal proliferators reported here.
